Open AccessNeurovascular protection in voltage‐gated proton channel Hv1 knock‐out rats after ischemic stroke: interaction with Na + /H + exchanger‐1 antagonism
Author(s) -
Li Weiguo,
Ward Rebecca,
Dong Guangkuo,
Ergul Adviye,
O'Connor Paul
Publication year - 2019
Publication title -
physiological reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 39
ISSN - 2051-817X
DOI - 10.14814/phy2.14142
Subject(s) - nadph oxidase , stroke (engine) , ischemia , pharmacology , neurovascular bundle , medicine , sodium–hydrogen antiporter , reactive oxygen species , microglia , anesthesia , chemistry , inflammation , biochemistry , pathology , sodium , mechanical engineering , organic chemistry , engineering
Abstract Experimental studies have demonstrated protective effects of NHE ‐1 inhibition on cardiac function; however, clinical trials utilizing NHE ‐1 antagonists found an increase in overall mortality attributed to thromboembolic strokes. NADPH oxidase‐derived reactive oxygen species ( ROS ) from microglial cells have been shown to contribute to injury following stroke. We have recently demonstrated that NHE ‐1 inhibition enhances ROS in macrophages in a Hv1‐dependent manner. As Hv1 protein is highly expressed in microglia, we hypothesized that “ NHE ‐1 inhibition may augment neurovascular injury by activating Hv1,” providing a potential mechanism for the deleterious effects of NHE ‐1. The goal of this study was to determine whether neurovascular injury and functional outcomes after experimental stroke differed in wild‐type and Hv1 mutant Dahl salt‐sensitive rats treated with an NHE ‐1 inhibitor. Stroke was induced using both transient and permanent of middle cerebral artery occlusion ( MCAO ). Animals received vehicle or NHE ‐1 inhibitor KR 32568 (2 mg/kg, iv) either 30 min after the start of MCAO or were pretreated (2 mg/kg, iv, day) for 3 days and then subjected to MCAO . Our data indicate that Hv1 deletion confers both neuronal and vascular protection after ischemia. In contrast to our hypothesis, inhibition of NHE ‐1 provided further protection from ischemic stroke, and the beneficial effects of both pre‐ and post‐treatment with KR 32568 were similar in wild‐type and Hv1 −/− rats. These data indicate that Hv1 activation is unlikely to be responsible for the increased incidence of cerebrovascular events observed in the heart disease patients after NHE ‐1 inhibition treatment.